IMPACT STATEMENT
Concerns on the long-term efficacy and safety of current treatments for pediatric AD have propelled the search for therapeutic alternatives, including postbiotics. This study compares the efficacy and safety of different postbiotic preparations for treating pediatric AD. This NMA shows biotherapeutic potential of inanimate Lactobacillus rhamnosus. Our findings may assist healthcare professionals in making evidence-based decisions for pediatric AD patients and enrich our current microbial research focusing on biotics .